I believe there are a few more differences between building a building vs an implant for example. A building will have a timeline that is more necessary to follow. Buildings will usually have a shorter building timeline in comparison with a product. It is more critical to follow the timeline because permits and other things needed to construct a skyscraper in a metropolitan area is vastly different from making an implant in an R&D and manufacturing building. Buildings also have more variability in the timeline such as weather. Weather doesn’t affect the timeline of an implant project. There are also more inspectors and government officials that check in on a building to make sure it’s up to code, while an implant would see more intricate documentation via the FDA. An implant has probably one team while a building would have multiple teams working such as architects, electricians, plumbers, etc. all of whom can square the blame for a holdup while a BME team shoulders it alone. A implant project leader has no one to blame other than him or her self. There is a lot more failure when comparing projects that make implants compared to those building buildings like skyscrapers. They are quite literally “too big to fail” due to the time and money spent planning, so no matter what they have to make it work.